Android app Apple app link

IBD Stock Of The Day ADMA Makes Bullish Comeback

By Investor's Business Daily   |   1 month ago
IBD Stock Of The Day ADMA Makes Bullish Comeback

ADMA Biologics is making a bullish comeback after an accounting issue. Analysts predict a path to $1.9 billion in sales for its product Asceniv. The company's improvement plans include a new process for more immunoglobulin yield, potentially driving significant sales upside.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.